Caris Life Sciences CAI
NASDAQ CAI
$28.30 -0.05 (-0.18%)
At close: Oct 2, 2026 · 4:00 PM EDT

Caris Life Sciences (CAI) Price to Sales (2025 - 2026)

Updated

Caris Life Sciences' (CAI) Price to Sales was 5.09 for Q2 2026, up 56.6% from 3.25 a year earlier but down 8.6% from the prior quarter.

Analysis

Caris Life Sciences (CAI) Price to Sales (2025 - 2026) Analysis & Trends

For FY2025, Price to Sales at Caris Life Sciences was 5.56.

  • Five-year quarterly Price to Sales spans a low of 3.25 in Q2 2025 and a high of 13.15 in Q3 2025.
  • Per Business Quant data, the three quarters before Q2 2026 came in at 5.57 (Q1 2026), 5.56 (Q4 2025) and 13.15 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 93.08 Bn 92.52 Bn -
2 Natera 58.93 Bn 54.61 Bn 485.19 Mn
3 Quest Diagnostics 25.75 Bn 24.18 Bn 1.03 Bn
4 Labcorp Holdings 24.96 Bn 22.73 Bn 1.11 Bn
5 Guardant Health 23.76 Bn 19.82 Bn 219.03 Mn
6 Tenet Healthcare 20.83 Bn 11.98 Bn -
7 Tempus AI 13.43 Bn 10.46 Bn 246.50 Mn
8 BrightSpring Health Services 11.90 Bn 10.24 Bn 492.75 Mn
9 Encompass Health 11.82 Bn 12.29 Bn -
10 Caris Life Sciences 8.00 Bn 4.82 Bn 179.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.09
Mar 31, 2026 5.57
Dec 31, 2025 5.56
Sep 30, 2025 13.15
Jun 30, 2025 3.25
API Access

Caris Life Sciences Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=CAI&period=max&api_key=YOUR_API_KEY